News
Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...
Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results